{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:49:09Z","timestamp":1788965349130,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX24_0933"],"award-info":[{"award-number":["SJCX24_0933"]}]},{"name":"Jiangsu Province Hospital of Chinese Medicine Department Director Academic Promotion Fund","award":["Y2022ZR02"],"award-info":[{"award-number":["Y2022ZR02"]}]},{"name":"Academic Inheritance and Communication Project of the China Academy of Chinese Medical Sciences","award":["CI2022E021XB"],"award-info":[{"award-number":["CI2022E021XB"]}]},{"name":"Academic Inheritance and Communication Project of the China Academy of Chinese Medical Sciences","award":["CI2022E021XB"],"award-info":[{"award-number":["CI2022E021XB"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04407-8","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T04:31:02Z","timestamp":1734669062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Lijia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"2","key":"4407_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.22141\/2307-1257.13.2.2024.456","volume":"13","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;13(2):140\u201371. https:\/\/doi.org\/10.22141\/2307-1257.13.2.2024.456","journal-title":"Kidney Int"},{"issue":"10","key":"4407_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1681\/ASN.2014070714","volume":"26","author":"S Thompson","year":"2015","unstructured":"Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504\u201311. https:\/\/doi.org\/10.1681\/ASN.2014070714","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"4407_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, et al. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"issue":"1","key":"4407_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"L Tao","year":"2022","unstructured":"Tao L, Xu J, Wang T, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. https:\/\/doi.org\/10.1186\/s12933-022-01511-x","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"4407_CR5","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and triglyceride\/glucose index. Diabetes Metab Syndr Clin Res Rev. 2022;16(8):102581. https:\/\/doi.org\/10.1016\/j.dsx.2022.102581","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"4407_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3634948","volume":"2016","author":"A Janus","year":"2016","unstructured":"Janus A, Szahidewicz-Krupska E, Mazur G, et al. Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediators Inflamm. 2016;2016:1\u201310. https:\/\/doi.org\/10.1155\/2016\/3634948","journal-title":"Mediators Inflamm"},{"issue":"4","key":"4407_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304. https:\/\/doi.org\/10.1089\/met.2008.0034","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"4407_CR8","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351. https:\/\/doi.org\/10.1210\/jc.2010-0288","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4407_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-024-02248-5","volume":"23","author":"D Liang","year":"2024","unstructured":"Liang D, Liu C, Wang Y. The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged\u2009\u2265\u200960 years: a population-based study. Cardiovasc Diabetol. 2024;23(1):151. https:\/\/doi.org\/10.1186\/s12933-024-02248-5","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4407_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-024-02120-6","volume":"23","author":"Y Yao","year":"2024","unstructured":"Yao Y, Wang B, Geng T, et al. The association between TyG and all-cause\/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):43. https:\/\/doi.org\/10.1186\/s12933-024-02120-6","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4407_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12944-023-01834-y","volume":"22","author":"W Chen","year":"2023","unstructured":"Chen W, Ding S, Tu J, et al. Association between the insulin resistance marker TyG index and subsequent adverse long-term cardiovascular events in young and middle-aged US adults based on obesity status. Lipids Health Dis. 2023;22(1):65. https:\/\/doi.org\/10.1186\/s12944-023-01834-y","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4407_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279. https:\/\/doi.org\/10.1186\/s12933-023-02030-z","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"4407_CR13","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski JW, Arnold SV, Butler J, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol. 2023;8(11):1050. https:\/\/doi.org\/10.1001\/jamacardio.2023.3241","journal-title":"JAMA Cardiol"},{"issue":"20","key":"4407_CR14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186","journal-title":"Circulation"},{"issue":"1","key":"4407_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195. https:\/\/doi.org\/10.1186\/s12933-023-01937-x","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"4407_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jcsm.12549","volume":"11","author":"JH Jhee","year":"2020","unstructured":"Jhee JH, Joo YS, Han SH, et al. High muscle-to-fat ratio is associated with lower risk of chronic kidney disease development. J Cachexia Sarcopenia Muscle. 2020;11(3):726\u201334. https:\/\/doi.org\/10.1002\/jcsm.12549","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"4407_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"1","key":"4407_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12933-023-02087-w","volume":"22","author":"F Xin","year":"2023","unstructured":"Xin F, He S, Zhou Y, et al. The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study. Cardiovasc Diabetol. 2023;22(1):347. https:\/\/doi.org\/10.1186\/s12933-023-02087-w","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4407_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-024-02209-y","volume":"23","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Gu Y, Zhang B. Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population. Cardiovasc Diabetol. 2024;23(1):111. https:\/\/doi.org\/10.1186\/s12933-024-02209-y","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4407_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12933-023-02089-8","volume":"23","author":"D Guo","year":"2024","unstructured":"Guo D, Wu Z, Xue F, et al. Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population. Cardiovasc Diabetol. 2024;23(1):39. https:\/\/doi.org\/10.1186\/s12933-023-02089-8","journal-title":"Cardiovasc Diabetol"},{"key":"4407_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14963","author":"Y Jia","year":"2024","unstructured":"Jia Y, Zhang Y, Bai S, et al. Triglyceride glucose index is a risk factor for heart failure: a prospective cohort study. ESC Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ehf2.14963","journal-title":"ESC Heart Fail"},{"issue":"1","key":"4407_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12933-022-01577-7","volume":"21","author":"Z Huang","year":"2022","unstructured":"Huang Z, Ding X, Yue Q, et al. Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):141. https:\/\/doi.org\/10.1186\/s12933-022-01577-7","journal-title":"Cardiovasc Diabetol"},{"key":"4407_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14947","author":"Z Fang","year":"2024","unstructured":"Fang Z, Raza U, Song J, et al. Systemic aging fuels heart failure: molecular mechanisms and therapeutic avenues. ESC Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ehf2.14947","journal-title":"ESC Heart Fail"},{"issue":"9","key":"4407_CR24","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/ndt\/gfad029","volume":"38","author":"M Bobot","year":"2023","unstructured":"Bobot M, Suissa L, Hak JF, et al. Kidney disease and stroke: epidemiology and potential mechanisms of susceptibility. Nephrol Dial Transpl. 2023;38(9):1940\u201351. https:\/\/doi.org\/10.1093\/ndt\/gfad029","journal-title":"Nephrol Dial Transpl"},{"key":"4407_CR25","doi-asserted-by":"publisher","unstructured":"Herbert BM, Johnson AE, Paasche-Orlow MK, et al. Disparities in reporting a history of cardiovascular disease among adults with Limited English proficiency and Angina. JAMA Netw Open. 2021;4(12). https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38780","DOI":"10.1001\/jamanetworkopen.2021.38780"},{"issue":"8","key":"4407_CR26","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s11255-024-04005-9","volume":"56","author":"K Li","year":"2024","unstructured":"Li K, Hou Q, Li X, et al. Triglyceride-glucose index predicts major adverse cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2024;56(8):2793\u2013802. https:\/\/doi.org\/10.1007\/s11255-024-04005-9","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4407_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-023-02028-7","volume":"22","author":"E Xie","year":"2023","unstructured":"Xie E, Ye Z, Wu Y, et al. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease. Cardiovasc Diabetol. 2023;22(1):292. https:\/\/doi.org\/10.1186\/s12933-023-02028-7","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"4407_CR28","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/ckj\/sfac073","volume":"15","author":"B Quiroga","year":"2022","unstructured":"Quiroga B, Mu\u00f1oz Ramos P, S\u00e1nchez Horrillo A, et al. Triglycerides\u2013glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease. Clin Kidney J. 2022;15(9):1705\u201312. https:\/\/doi.org\/10.1093\/ckj\/sfac073","journal-title":"Clin Kidney J"},{"issue":"4","key":"4407_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1159\/000500979","volume":"44","author":"Z Yan","year":"2019","unstructured":"Yan Z, Yu D, Cai Y, et al. Triglyceride glucose index predicting cardiovascular mortality in Chinese initiating peritoneal dialysis: a cohort study. Kidney Blood Press Res. 2019;44(4):669\u201378. https:\/\/doi.org\/10.1159\/000500979","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"4407_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.RV22012","volume":"31","author":"H Ogata","year":"2024","unstructured":"Ogata H, Sugawara H, Yamamoto M, et al. Phosphate and coronary artery disease in patients with chronic kidney disease. J Atheroscler Thromb. 2024;31(1):1\u201314. https:\/\/doi.org\/10.5551\/jat.RV22012","journal-title":"J Atheroscler Thromb"},{"issue":"13","key":"4407_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/CS20220797","volume":"138","author":"J Toto\u0144-\u017bura\u0144ska","year":"2024","unstructured":"Toto\u0144-\u017bura\u0144ska J, Mikolajczyk TP, Saju B, et al. Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation. Clin Sci (Lond). 2024;138(13):817\u201350. https:\/\/doi.org\/10.1042\/CS20220797","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"4407_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s11255-022-03433-9","volume":"55","author":"N Liu","year":"2022","unstructured":"Liu N, Liu C, Qu Z, et al. Association between the triglyceride-glucose index and chronic kidney disease in adults. Int Urol Nephrol. 2022;55(5):1279\u201389. https:\/\/doi.org\/10.1007\/s11255-022-03433-9","journal-title":"Int Urol Nephrol"},{"issue":"16","key":"4407_CR33","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s11606-024-08809-4","volume":"39","author":"D Yoshida","year":"2024","unstructured":"Yoshida D, Ikeda S, Shinohara K, et al. Triglyceride-glucose index associated with future renal function decline in the general population. J Gen Intern Med. 2024;39(16):3225\u201333. https:\/\/doi.org\/10.1007\/s11606-024-08809-4","journal-title":"J Gen Intern Med"},{"issue":"1","key":"4407_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12944-020-01401-9","volume":"19","author":"J Wen","year":"2020","unstructured":"Wen J, Wang A, Liu G, et al. Elevated triglyceride-glucose (TyG) index predicts incidence of prediabetes: a prospective cohort study in China. Lipids Health Dis. 2020;19(1):226. https:\/\/doi.org\/10.1186\/s12944-020-01401-9","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4407_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12967-023-04402-1","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen X, Liu D, He W, et al. Predictive performance of triglyceride glucose index (TyG index) to identify glucose status conversion: a 5-year longitudinal cohort study in Chinese pre-diabetes people. J Transl Med. 2023;21(1):624. https:\/\/doi.org\/10.1186\/s12967-023-04402-1","journal-title":"J Transl Med"},{"issue":"7","key":"4407_CR36","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/HYPERTENSIONAHA.124.23087","volume":"81","author":"G Santulli","year":"2024","unstructured":"Santulli G, Visco V, Varzideh F, et al. Prediabetes increases the risk of frailty in prefrail older adults with hypertension: beneficial effects of metformin. Hypertension. 2024;81(7):1637\u201343. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.124.23087","journal-title":"Hypertension"},{"key":"4407_CR37","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Liu H, Zhang F, et al. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol. 2022;13:951689. https:\/\/doi.org\/10.3389\/fendo.2022.951689","journal-title":"Front Endocrinol"},{"issue":"1","key":"4407_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"issue":"1\u20132","key":"4407_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2013.02.005","volume":"378","author":"R Nistala","year":"2013","unstructured":"Nistala R, Whaley-Connell A. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II. Mol Cell Endocrinol. 2013;378(1\u20132):53\u20138. https:\/\/doi.org\/10.1016\/j.mce.2013.02.005","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"4407_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/er.2007-0006","volume":"28","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, et al. Cardiovascular actions of insulin. Endocr Rev. 2007;28(5):463\u201391. https:\/\/doi.org\/10.1210\/er.2007-0006","journal-title":"Endocr Rev"},{"issue":"1","key":"4407_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"4407_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"JA Kim","year":"2008","unstructured":"Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102(4):401\u201314. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165472","journal-title":"Circ Res"},{"issue":"10","key":"4407_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345. https:\/\/doi.org\/10.1038\/s41581-023-00741-w","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4407_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371. https:\/\/doi.org\/10.1016\/j.cell.2012.02.017","journal-title":"Cell"},{"issue":"2","key":"4407_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/en.2010-1038","volume":"152","author":"J Habibi","year":"2011","unstructured":"Habibi J, Hayden MR, Sowers JR, et al. Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology. 2011;152(2):659\u201368. https:\/\/doi.org\/10.1210\/en.2010-1038","journal-title":"Endocrinology"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04407-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04407-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04407-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:13:50Z","timestamp":1734671630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04407-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04407-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES study received approval from the National Center for Health Statistics and the Ethics Review Board. In accordance with NHANES protocol, all participants in the NHANES study provided written informed consent. Detailed information about the NHANES protocol and ethical review process is available at . As this study utilized publicly available data from the NHANES database, no additional ethical approval or consents were required. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"723"}}